These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26444353)

  • 101. Rituximab as Treatment for Lupus Nephritis: Data From the Peruvian ALMENARA Lupus Cohort.
    Pimentel-Quiroz VR; Reátegui-Sokolova C; Gamboa-Cárdenas RV; Elera-Fitzcarrald C; Rodríguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    J Clin Rheumatol; 2024 Sep; 30(6):235-238. PubMed ID: 38956657
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index.
    Usiskin IM; Kyttaris VC
    Lupus; 2023 Apr; 32(4):565-570. PubMed ID: 36825983
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Rituximab therapy in lupus nephritis: current clinical evidence.
    Ramos-Casals M; Diaz-Lagares C; Soto-Cardenas MJ; Brito-Zeron P; Cuadrado MJ; Sanna G; Bertolaccini L; Khamashta MA
    Clin Rev Allergy Immunol; 2011 Jun; 40(3):159-69. PubMed ID: 20419398
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Phosphorylated vimentin at Ser72 is associated with epithelial-mesenchymal transition in lupus nephritis.
    Wang D; Zhang F; He J; Li C; Liu X; Zhang M; Huang H; Xiong Z; Duan H; Huang X; Wang M
    Int J Rheum Dis; 2024 Jan; 27(1):e14990. PubMed ID: 38078507
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report.
    Yoshida M; Hirashio S; Doi T; Masuda Y; Shimizu A; Masaki T
    Case Rep Nephrol Dial; 2021; 11(1):36-47. PubMed ID: 33708798
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Clinical impact of repeat renal biopsies in patients with lupus nephritis: Renal biopsy is essential especially later in the course of the disease.
    Marinaki S; Kapsia E; Liapis G; Gakiopoulou H; Skalioti C; Kolovou K; Boletis J
    Eur J Rheumatol; 2020 Jan; 7(1):2-8. PubMed ID: 31782721
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects - A 5-month study.
    Zhao Z; Jia Z; Foster KW; Wei X; Qiao F; Jiang H; Jin Y; Li G; Chen N; Zhao G; Thiele GM; Medlin JL; O'Dell JR; Wang D
    Nanomedicine; 2021 Jan; 31():102302. PubMed ID: 32980548
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Revisiting Vasculopathy in Lupus Nephritis: A Renal Biopsy Evaluation Study.
    Lakshmi VR; Vangala N; Uppin MS; Gudithi S; Taduri G; Raju SB
    Indian J Nephrol; 2022; 32(1):28-33. PubMed ID: 35283572
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis.
    Pedrosa TN; Pasoto SG; Aikawa NE; Yuki EF; Borba EF; Filho JCF; Carricondo PC; Zanetti CB; Conde PG; Duarte NJ; Fontoura N; Romano P; Carvalho VM; Silva CA; Bonfa E
    Lupus; 2020 May; 29(6):560-568. PubMed ID: 32192398
    [No Abstract]   [Full Text] [Related]  

  • 110. Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.
    Contis A; Vanquaethem H; Truchetet ME; Couzi L; Rigothier C; Richez C; Lazaro E; Duffau P
    Clin Rheumatol; 2016 Feb; 35(2):517-22. PubMed ID: 26762196
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Lupus nephritis: an update.
    Imran TF; Yick F; Verma S; Estiverne C; Ogbonnaya-Odor C; Thiruvarudsothy S; Reddi AS; Kothari N
    Clin Exp Nephrol; 2016 Feb; 20(1):1-13. PubMed ID: 26471017
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Exacerbation of lupus nephritis by high sodium chloride related to activation of SGK1 pathway.
    Yang X; Yao G; Chen W; Tang X; Feng X; Sun L
    Int Immunopharmacol; 2015 Dec; 29(2):568-573. PubMed ID: 26474695
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus.
    Stypińska B; Paradowska-Gorycka A
    Int J Mol Sci; 2015 Oct; 16(10):24194-218. PubMed ID: 26473848
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.
    Virdis A; Tani C; Duranti E; Vagnani S; Carli L; Kühl AA; Solini A; Baldini C; Talarico R; Bombardieri S; Taddei S; Mosca M
    Arthritis Res Ther; 2015 Oct; 17():277. PubMed ID: 26444671
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Living with invisible illness: social support experiences of individuals with systemic lupus erythematosus.
    Brennan KA; Creaven AM
    Qual Life Res; 2016 May; 25(5):1227-35. PubMed ID: 26449351
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity.
    Midgley A; Beresford MW
    Lupus; 2016 Apr; 25(4):407-11. PubMed ID: 26453665
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Methylation and gene expression of histone deacetylases 6 in systemic lupus erythematosus.
    Fang TJ; Lin YZ; Liu CC; Lin CH; Li RN; Wu CC; Ou TT; Tsai WC; Yen JH
    Int J Rheum Dis; 2016 Oct; 19(10):968-973. PubMed ID: 26461065
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Lupus-like eruption as the presenting sign of acute myeloblastic leukemia.
    Cedeno-Laurent F; Obstfeld AE; Boni A; Lipoff JB
    Lupus; 2016 Mar; 25(3):312-4. PubMed ID: 26466615
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.
    Black LL; Srivastava R; Schoeb TR; Moore RD; Barnes S; Kabarowski JH
    J Immunol; 2015 Nov; 195(10):4685-98. PubMed ID: 26466956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.